Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma

BACKGROUND: The purpose of this study was to evaluate amifostine for protection from cisplatin-induced serious hearing loss in patients with average-risk medulloblastoma by extending a previous analysis to a much larger sample size. In addition, this study aimed to assess amifostine with serious hea...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Gurney, James G., Bass, Johnnie K., Onar-Thomas, Arzu, Huang, Jie, Chintagumpala, Murali, Bouffet, Eric, Hassall, Tim, Gururangan, Sridharan, Heath, John A., Kellie, Stewart, Cohn, Richard, Fisher, Michael J., Panandiker, Atmaram Pai, Merchant, Thomas E., Srinivasan, Ashok, Wetmore, Cynthia, Qaddoumi, Ibrahim, Stewart, Clinton F., Armstrong, Gregory T., Broniscer, Alberto, Gajjar, Amar
Format: Artigo
Język:Inglês
Wydane: Oxford University Press 2014
Hasła przedmiotowe:
Pediatric Neuro-Oncology
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4022215/
https://ncbi.nlm.nih.gov/pubmed/24414535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/not241
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy